Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Privia Health Group, Inc. - Common Stock (NQ:PRVA)

22.80 -0.21 (-0.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Privia Health Group, Inc. - Common Stock

< Previous 1 2 3 4 Next >
PRVA Q1 Earnings Call: Arizona Expansion and Value-Based Care Execution Offset Revenue Miss
Healthcare tech company Privia Health Group (NASDAQ:PRVA) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 15.6% year on year to $480.1 million. Its non-GAAP EPS of $0.22 per... 
Via StockStory
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 to Think Twice About
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
11 Analysts Have This To Say About Privia Health Gr
Via Benzinga
3 Healthcare Stocks with Mounting Challenges
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Earnings Scheduled For May 8, 2025
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
What Analysts Are Saying About Privia Health Gr Stock
Via Benzinga
A Glimpse Into The Expert Outlook On Privia Health Gr Through 6 Analysts
Via Benzinga
Unpacking Q1 Earnings: Privia Health (NASDAQ:PRVA) In The Context Of Other Healthcare Technology for Providers Stocks
Looking back on healthcare technology for providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Privia Health (NASDAQ:PRVA) and its peers. 
Via StockStory
3 Dawdling Stocks with Mounting Challenges
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
Topics Supply Chain
Exposures Supply Chain
Privia Health (NASDAQ:PRVA) Exceeds Q1 Expectations
Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 15.6% year on year to $480.1 million. On the other hand,... 
Via StockStory
Privia Health (PRVA) Reports Earnings Tomorrow: What To Expect
Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be reporting results tomorrow before the bell. Here’s what to look for. 
Via StockStory
Key Takeaways From Privia Health Gr Analyst Ratings
Via Benzinga
Forecasting The Future: 7 Analyst Projections For Privia Health Gr
Via Benzinga
3 Stocks Under $50 That Concern Us
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
Q4 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks
Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Premier (NASDAQ:PINC) and its peers. 
Via StockStory
Topics Economy
Exposures Supply Chain
Investigating Privia Health Gr's Standing In Health Care Providers &amp; Services Industry Compared To Competitors
Via Benzinga
Q4 Rundown: Astrana Health (NASDAQ:ASTH) Vs Other Healthcare Technology for Providers Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers. 
Via StockStory
Assessing Privia Health Gr: Insights From 10 Financial Analysts
Via Benzinga
1 of Wall Street’s Favorite Stock to Research Further and 2 to Steer Clear Of
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Care
CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care. 
Via Benzinga
How Is The Market Feeling About Privia Health Gr?
Via Benzinga
2 Reasons to Sell PRVA and 1 Stock to Buy Instead
Even during a down period for the markets, Privia Health has gone against the grain, climbing to $22.91. Its shares have yielded a 29.3% return over the last six months, beating the S&P 500 by 30.9%.... 
Via StockStory
Topics Stocks Supply Chain
Exposures Supply Chain US Equities
1 Healthcare Stock with Solid Fundamentals and 2 to Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Breaking Down Privia Health Gr: 10 Analysts Share Their Views
Via Benzinga
Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (NYSE:PHR) and its peers. 
Via StockStory
Phreesia (PHR) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare technology company Phreesia (NYSE:PHR) will be reporting results tomorrow after the bell. Here’s what to look for. 
Via StockStory
3 Stocks Under $50 Walking a Fine Line
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
Via StockStory
Privia Health (NASDAQ:PRVA) Surprises With Q4 Sales But Full-Year Sales Guidance Misses Expectations
Healthcare tech company Privia Health Group (NASDAQ:PRVA) announced better-than-expected revenue in Q4 CY2024, with sales up 4.6% year on year to $460.9 million. On the other hand, the company’s... 
Via StockStory
Privia Health (PRVA) Q4 Earnings Report Preview: What To Look For
Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be announcing earnings results tomorrow before market open. Here’s what to expect. 
Via StockStory
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.